Pulmonary fibrosis

被引：1

作者：

Gomez Carrera, Luis ^{[1
]}

Alvarez-Sala Walther, Rodolfo ^{[1
]}

机构：

[1] Univ Autonoma Madrid, Hosp Univ La Paz, Inst Invest Hosp Univ Paz IdiPAZ, Serv Neumol,Dept Med, Madrid, Spain

来源：

MEDICINA CLINICA | 2016年 / 146卷 / 03期

关键词：

PIRFENIDONE; NINTEDANIB; DIAGNOSIS; ACETYLCYSTEINE; GUIDELINES; EFFICACY; SAFETY; TRIAL;

D O I：

10.1016/j.medcli.2015.06.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：115 / 116

页数：2

共 21 条

[1]

Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646

[2]

American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277

[3]

Ancochea J., 2010, ARCH BRONCONEUMOL, V46, P2

[4]

Katzenstein A L, 1993, Monogr Pathol, P1

[5] A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis [J].

King, Talmadge E., Jr. ;

Bradford, Williamson Z. ;

Castro-Bernardini, Socorro ;

Fagan, Elizabeth A. ;

Glaspole, Ian ;

Glassberg, Marilyn K. ;

Gorina, Eduard ;

Hopkins, Peter M. ;

Kardatzke, David ;

Lancaster, Lisa ;

Lederer, David J. ;

Nathan, Steven D. ;

Pereira, Carlos A. ;

Sahn, Steven A. ;

Sussman, Robert ;

Swigris, Jeffrey J. ;

Noble, Paul W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) :2083-2092

[6] Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis [J].

Martinez, Fernando J. ;

de Andrade, Joao A. ;

Anstrom, Kevin J. ;

King, Talmadge E., Jr. ;

Raghu, Ganesh .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) :2093-2101

[7]

Muller NL, 1997, RADIOGRAPHICS, V17, P1016

[8] Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials [J].

Noble, Paul W. ;

Albera, Carlo ;

Bradford, Williamson Z. ;

Costabel, Ulrich ;

Glassberg, Marilyn K. ;

Kardatzke, David ;

King, Talmadge E., Jr. ;

Lancaster, Lisa ;

Sahn, Steven A. ;

Szwarcberg, Javier ;

Valeyre, Dominique ;

du Bois, Roland M. .

LANCET, 2011, 377 (9779) :1760-1769

[9] Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis [J].

Ogura, Takashi ;

Taniguchi, Hiroyuki ;

Azuma, Arata ;

Inoue, Yoshikazu ;

Kondoh, Yasuhiro ;

Hasegawa, Yoshinori ;

Bando, Masashi ;

Abe, Shinji ;

Mochizuki, Yoshiro ;

Chida, Kingo ;

Klueglich, Matthias ;

Fujimoto, Tsuyoshi ;

Okazaki, Kotaro ;

Tadayasu, Yusuke ;

Sakamoto, Wataru ;

Sugiyama, Yukihiko .

EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) :1382-1392

[10] Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone - Results of a prospective, open-label phase II study [J].

Raghu, G ;

Johnson, WC ;

Lockhart, D ;

Mageto, Y .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (04) :1061-1069

← 1 2 3 →